Genetic defects affecting the interferon-gamma (IFNγ)/interleukin-12 axis and autoantibodies to IFNγ have been described as predisposing factors for active clinical infections with weakly virulent mycobacteria in apparently immunocompetent hosts.1 This evidence concerns the gene IFNG and infection.